Page last updated: 2024-12-07

berbine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Berbine is an alkaloid found in plants of the Berberidaceae family. It has a complex structure with a benzo[c]phenanthridine core and multiple substituents. Berbine exhibits a wide range of pharmacological activities, including anti-inflammatory, analgesic, and anticancer properties. Its potential as an anticancer agent is particularly interesting, as it has shown activity against various cancer cell lines. The mechanism of its anticancer activity involves inhibiting the proliferation and inducing apoptosis of cancer cells. Berbine's unique structural features and biological activity make it a promising target for further research and development of novel therapeutic agents. Researchers study berbine to understand its mechanisms of action and its potential for treating various diseases.'

berbine: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID101707
CHEBI ID35611
SCHEMBL ID659757
MeSH IDM0063665

Synonyms (18)

Synonym
CHEBI:35611
483-49-8
berbine
5,8,13,13a-tetrahydro-6h-dibenzo[a,g]quinolizine
5,6,7,8,13,13a-hexahydro-isoquinolino[3,2-a]isoquinoline
728c74fb5z ,
6h-dibenzo(a,g)quinolizine, 5,8,13,13a-tetrahydro-
unii-728c74fb5z
SCHEMBL659757
(+/-)-tetrahydroprotoberberine
dl-tetrahydroprotoberberine
41173-75-5
5,8,13,13a-tetrahydro-6h-dibenzo(a,g)quinolizine
berbine [mi]
berbin
protoberberine, tetrahydro-
Q27116529
DTXSID70870550

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
" Importantly, compound 49 displayed superior bioavailability (F = 65."( Design, synthesis, and biological evaluation of novel tetrahydroprotoberberine derivatives to reduce SREBPs expression for the treatment of hyperlipidemia.
Chen, W; Cheng, H; Ge, H; Xie, Y; Xu, X; Xue, H; Yang, P; Yuan, K; Zhang, J; Zhang, W, 2021
)
0.62
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (3)

ClassDescription
berberine alkaloid
isoquinoline alkaloid fundamental parent
organic heterotetracyclic compound
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (45)

TimeframeStudies, This Drug (%)All Drugs %
pre-199010 (22.22)18.7374
1990's5 (11.11)18.2507
2000's6 (13.33)29.6817
2010's19 (42.22)24.3611
2020's5 (11.11)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 64.37

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index64.37 (24.57)
Research Supply Index3.85 (2.92)
Research Growth Index5.03 (4.65)
Search Engine Demand Index212.77 (26.88)
Search Engine Supply Index4.00 (0.95)

This Compound (64.37)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews3 (6.52%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other43 (93.48%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]